Financials Double Medical Technology Inc.

Equities

002901

CNE1000032W7

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
31.33 CNY +3.23% Intraday chart for Double Medical Technology Inc. +10.71% -22.81%

Valuation

Fiscal Period: December 2018 2021 2022 2023 2024 2025
Capitalization 1 11,839 20,310 14,062 12,971 12,971 -
Enterprise Value (EV) 1 11,839 20,310 14,062 16,805 12,971 12,971
P/E ratio 31.8 x 30.3 x 155 x 290 x 26.1 x 19.5 x
Yield - - - - - -
Capitalization / Revenue 15.3 x 10.2 x - 11 x 6.47 x 4.93 x
EV / Revenue 15.3 x 10.2 x - 11 x 6.47 x 4.93 x
EV / EBITDA - 22.6 x - 58.4 x 18.9 x 14.3 x
EV / FCF - - - - - -
FCF Yield - - - - - -
Price to Book 8.26 x 8.08 x - 5.49 x 3.61 x 3.24 x
Nbr of stocks (in thousands) 400,100 401,232 413,232 414,020 414,020 -
Reference price 2 29.59 50.62 34.03 31.33 31.33 31.33
Announcement Date 1/30/19 3/29/22 4/28/23 3/29/24 - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2021 2022 2023 2024 2025
Net sales 1 772.5 1,994 - 1,533 2,004 2,633
EBITDA 1 - 897.8 - 287.5 686 904
EBIT 1 440.8 822 - 103.2 704 935
Operating Margin 57.06% 41.22% - 6.73% 35.13% 35.51%
Earnings before Tax (EBT) 1 440.7 802.5 - 99.74 695 929
Net income 1 371.5 673.3 - 58.97 498 667
Net margin 48.09% 33.76% - 3.85% 24.85% 25.33%
EPS 2 0.9300 1.670 0.2200 0.1400 1.200 1.610
Free Cash Flow - - - - - -
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 1/30/19 3/29/22 4/28/23 3/29/24 - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2024 Q1
Net sales 1 469
EBITDA -
EBIT -
Operating Margin -
Earnings before Tax (EBT) -
Net income 1 75
Net margin 15.99%
EPS -
Dividend per Share -
Announcement Date -
1CNY in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2021 2023 2024 2025
Net Debt - - - - -
Net Cash position - - - - -
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow - - - - -
ROE (net income / shareholders' equity) 28.1% 26.7% 1.95% 13.9% 16.6%
ROA (Net income/ Total Assets) - - 4.4% 10.4% 11.6%
Assets 1 - - 4,159 4,788 5,750
Book Value Per Share 2 3.580 6.260 7.390 8.670 9.680
Cash Flow per Share 0.8300 1.670 - - -
Capex 1 - - 304 250 230
Capex / Sales - - 19.84% 12.48% 8.74%
Announcement Date 1/30/19 3/29/22 3/29/24 - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
31.33 CNY
Average target price
48 CNY
Spread / Average Target
+53.21%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 002901 Stock
  4. Financials Double Medical Technology Inc.